A total of 1,091 patients with type 2 diabetes and HbA 1c levels of 7.5–11.0% were randomly assigned to receive combination therapy with daily sitagliptin (100 mg) and metformin (either 1,000 mg ...
effectiveness and tolerability while not exceeding the maximum recommended daily dose of sitagliptin 100 mg and metformin 2000 mg. Janumet should generally be administered twice daily with meals ...
The Food and Drug Administration (FDA) has expanded the list of medicines for non-communicable diseases (NCDs) exempted from ...
Patients in each stratum were randomized to sitagliptin 100 mg once daily or placebo. Sitagliptin significantly decreased HbA 1c levels from baseline relative to placebo in the overall cohort as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback